Bangladesh bans ranitidine

With regulatory bodies in the U.S. and EU investigating the presence of a probable carcinogen in ranitidine, Bangladesh has placed an outright ban on the popular heartburn drug.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news